Alveolar soft‐part sarcoma: Primary metastatic disease and metastatic relapse occurring during long‐term follow‐up

Patients with metastatic alveolar soft‐part sarcoma (ASPS) are known to have a very poor prognosis. Little is known about best treatment of primary metastatic disease (MD) or relapsed metastatic disease (rMD).

[1]  Ricardo J. Flores,et al.  Alveolar soft part sarcoma in children and young adults: A report of 69 cases , 2018, Pediatric blood & cancer.

[2]  A. Ferrari,et al.  Alveolar soft part sarcoma in children and adolescents: The European Paediatric Soft Tissue Sarcoma study group prospective trial (EpSSG NRSTS 2005) , 2018, Pediatric blood & cancer.

[3]  J. G. Glade Bender,et al.  Treatment of Metastatic, Refractory Alveolar Soft Part Sarcoma: Case Reports and Literature Review of Treatment Options in the Era of Targeted Therapy , 2016, Journal of pediatric hematology/oncology.

[4]  A. Jacobson,et al.  Prognostic factors in alveolar soft part sarcoma: A SEER analysis , 2016, Journal of surgical oncology.

[5]  C. Wittekind,et al.  Neue TNM-Klassifikation der Lungentumoren , 2014, Der Pathologe.

[6]  James Brierley,et al.  Improving the TNM classification: Findings from a 10‐year continuous literature review , 2014, International journal of cancer.

[7]  G. Ott,et al.  Lung Metastasis of Primary Alveolar Soft-Part Sarcoma Occurring 20 Years after Initial Treatment , 2013, Case reports in oncological medicine.

[8]  A. Ferrari,et al.  Paediatric and adolescent alveolar soft part sarcoma: A joint series from European cooperative groups , 2013, Pediatric blood & cancer.

[9]  S. Steinberg,et al.  Cediranib for metastatic alveolar soft part sarcoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  A. Kawai,et al.  Alveolar Soft Part Sarcoma: A Single-Center 26-Patient Case Series and Review of the Literature , 2012, Sarcoma.

[11]  H. Brisse,et al.  Alveolar soft part sarcoma in childhood: Is Sunitinib‐Sutent® treatment an effective approach? , 2012, Pediatric blood & cancer.

[12]  L. Mariani,et al.  Non-metastatic unresected paediatric non-rhabdomyosarcoma soft tissue sarcomas: results of a pooled analysis from United States and European groups. , 2011, European journal of cancer.

[13]  R. Grimer,et al.  Detection of ASPL/TFE3 fusion transcripts and the TFE3 antigen in formalin-fixed, paraffin-embedded tissue in a series of 18 cases of alveolar soft part sarcoma: Useful diagnostic tools in cases with unusual histological features , 2011, Virchows Archiv.

[14]  R. Schmelzle,et al.  Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  P. Casali,et al.  Response to Sunitinib Malate in Advanced Alveolar Soft Part Sarcoma , 2009, Clinical Cancer Research.

[16]  T. Acker,et al.  Vascular-endothelial-growth-factor (VEGF) expression and possible response to angiogenesis inhibitor bevacizumab in metastatic alveolar soft part sarcoma. , 2006, The Lancet. Oncology.

[17]  Andrea Ferrari,et al.  Adult-type soft tissue sarcomas in pediatric-age patients: experience at the Istituto Nazionale Tumori in Milan. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  B. Meister,et al.  Treatment for soft tissue sarcoma in childhood and adolescence , 2005, Wiener klinische Wochenschrift.

[19]  B. Dörken,et al.  Chemotherapy in alveolar soft part sarcomas. What do we know? , 2003, European journal of cancer.

[20]  Alfons Meindl,et al.  The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25 , 2001, Oncogene.

[21]  B. Bernardi,et al.  Alveolar soft part sarcoma in children and adolescents: A report from the Soft-Tissue Sarcoma Italian Cooperative Group. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  L. Sobin,et al.  How to improve the present TNM staging system , 1999, Cancer.

[23]  G. Henze,et al.  Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  D. Niethammer,et al.  [Improved local tumor control by early and risk-adjusted use of radiotherapy in primary non-resectable rhabdomyosarcomas: results of CWS 81 and 86 studies]. , 1994, Klinische Pädiatrie.

[25]  H. Jürgens,et al.  Treatment of soft tissue sarcoma in childhood and adolescence: A report of the german cooperative soft tissue sarcoma study , 1992, Cancer.

[26]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[27]  André M. Oliveira,et al.  Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases , 2014, Modern Pathology.

[28]  W. Gerald,et al.  Clinical presentation, treatment, and outcome of alveolar soft part sarcoma in children, adolescents, and young adults. , 2006, Journal of pediatric surgery.